Form D Explorer

Form C/A — Diant Pharma Inc.

0001665160-25-000411 · filed 2025-03-12 · via StartEngine Primary, LLC

Offering

Target: $19,999
Maximum: $1,234,998
Security type: Other
Price per security: $1.8800
Deadline: —
Oversubscription: Accepted

Issuer

Name: Diant Pharma Inc.
CIK: 1949139
Entity: Corporation
Jurisdiction: DE
Address: 130 UTOPIA ROAD, UNIT 12
MANCHESTER, CT 06042
Phone: —

Most recent fiscal year financials

Total assets

$2,210,077

Cash

—

Short-term debt

$118,710

Long-term debt

$122,445

Revenues

$1,768,135

COGS

$788,342

Taxes paid

—

Net income

$-323,013

View original on SEC EDGAR.